MedTrace Logo

Assessment of Novel Sound Changing Principles in Hearing Instruments to Determine Their Application

NCT03780374 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-05-09

No results posted yet for this study

Summary

A methodical evaluation of novel sound changing principles in CE-labelled Sonova brand hearing instruments (e.g. Phonak hearing instruments) is intended to be conducted on hearing impaired. These sound changing principles are enabled by respective hearing instrument algorithms. The aim of the study is to investigate and asses strength and weaknesses of these novel sound changing principles in terms of hearing performance to determine their application in hearing instruments (Phase of development). Both, objective laboratory measurements as well as subjective evaluations in real life environment will be carried out. This will be a controlled, single blinded and randomized active comparator clinical evaluation which will be conducted mono-centric at Sonova AG Headquarter based in Staefa.

Conditions

Interventions

DEVICE

Phonak Audéo L2M with Sound Processing Principle 1

Compensation of a hearing loss with Sound Processing Principle 1.

DEVICE

Phonak Audéo L2M with Sound Processing Principle 2

Compensation of a hearing loss with Sound Processing Principle 2.

DEVICE

Phonak Audéo L2M with Sound Processing Principle 3

Compensation of a hearing loss with Sound Processing Principle 3.

Sponsors & Collaborators

  • Sonova AG

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-03
Primary Completion
2019-01-15
Completion
2019-03-15

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03780374 on ClinicalTrials.gov